Margit A. Huber
Impact in
- Cancer Research top 1%
- NF-κB Signaling Pathways
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 1%
- Cancer Cells and Metastasis
Papers in
- Oncology 12
- Cancer Cells and Metastasis 5
- Cytokine Signaling Pathways and Interactions 2
- CAR-T cell therapy research 2
-
- NF-κB Signaling Pathways 5
- Co-authors
- Hartmut Beug (6 shared papers)Norbert Kraut (7 shared papers)Thomas Wirth (6 shared papers)Hubert Pehamberger (5 shared papers)Bernd Baumann (2 shared papers)Andreas Sommer (2 shared papers)Stefan Grünert (2 shared papers)Ninel Azoitei (2 shared papers)
- Journals
- Journal of Clinical Investigation (2 papers)Advances in Therapy (2 papers)Genes & Cancer (1 paper)Journal of Cutaneous Pathology (1 paper)Journal of Investigative Dermatology (1 paper)
- Partner nations
- GermanyAustriaUnited Kingdom
In The Last Decade
Margit A. Huber
20 papers receiving 3.7k citations
Margit A. Huber's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 1.2k
- Oncology 1.8k
- Molecular Biology 2.3k
- Immunology and Allergy 164
- Cell Biology 353
Countries citing papers authored by Margit A. Huber
This map shows the geographic impact of Margit A. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margit A. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margit A. Huber more than expected).
Fields of papers citing papers by Margit A. Huber
This network shows the impact of papers produced by Margit A. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margit A. Huber. The network helps show where Margit A. Huber may publish in the future.
Co-authors
The 25 scholars most cited alongside Margit A. Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular requirements for epithelial–mesenchymal transition during tumor progression Hit paper breakdown → | 2005 | 1544 |
| 2 | NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression Hit paper breakdown → | 2004 | 780 |
| 3 | NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression Hit paper breakdown → | 2004 | 734 |
| 4 | 2010 | 180 | |
| 5 | 2003 | 136 | |
| 6 | 2004 | 111 | |
| 7 | 2002 | 53 | |
| 8 | 2006 | 51 | |
| 9 | 2014 | 32 | |
| 10 | 2000 | 19 | |
| 11 | 2018 | 18 | |
| 12 | 2010 | 15 | |
| 13 | 2020 | 15 | |
| 14 | 2006 | 10 | |
| 15 | 1995 | 5 | |
| 16 | 1995 | 5 | |
| 17 | 2014 | 4 | |
| 18 | 2000 | 3 | |
| 19 | 1995 | 1 | |
| 20 | 2010 | 1 |
About Margit A. Huber
Margit A. Huber is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Obstetrics and Gynecology, having authored 21 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), NF-κB Signaling Pathways (5 papers), TGF-β signaling in diseases (3 papers), Uterine Myomas and Treatments (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Virus-based gene therapy research (2 papers), CAR-T cell therapy research (2 papers) and Endometriosis Research and Treatment (2 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.8k citations), Molecular Biology (2.3k citations), Immunology and Allergy (164 citations) and Cell Biology (353 citations). Margit A. Huber has collaborated with scholars based in Germany, Austria and United Kingdom. Frequent co-authors include Hartmut Beug, Norbert Kraut, Thomas Wirth, Hubert Pehamberger, Bernd Baumann, Andreas Sommer, Stefan Grünert, Ninel Azoitei, Ralf Uwe Peter and U. Schmidt. Their work appears in journals such as Journal of Clinical Investigation, Advances in Therapy, Genes & Cancer, Journal of Cutaneous Pathology and Journal of Investigative Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.